Morgan Stanley Institutional Investment Advisors LLC Invests $217.39 Million in National HealthCare Corporation $NHC

Morgan Stanley Institutional Investment Advisors LLC acquired a new position in National HealthCare Corporation (NYSEAMERICAN:NHCFree Report) during the second quarter, HoldingsChannel.com reports. The institutional investor acquired 1,028,534 shares of the company’s stock, valued at approximately $217,391,000. National HealthCare comprises 20.3% of Morgan Stanley Institutional Investment Advisors LLC’s investment portfolio, making the stock its 3rd biggest holding. Morgan Stanley Institutional Investment Advisors LLC owned about 0.07% of National HealthCare as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd acquired a new position in National HealthCare during the 3rd quarter valued at about $25,000. Allworth Financial LP bought a new position in National HealthCare in the 2nd quarter worth about $27,000. Quarry LP increased its stake in shares of National HealthCare by 171.9% in the third quarter. Quarry LP now owns 261 shares of the company’s stock valued at $32,000 after purchasing an additional 165 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in shares of National HealthCare in the second quarter valued at approximately $37,000. Finally, Kestra Advisory Services LLC bought a new stake in shares of National HealthCare during the fourth quarter valued at approximately $42,000. 56.44% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, Director Lisa Piercey purchased 949 shares of the firm’s stock in a transaction on Monday, June 1st. The stock was purchased at an average cost of $184.26 per share, with a total value of $174,862.74. Following the purchase, the director owned 949 shares in the company, valued at $174,862.74. This trade represents a ∞ increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Stephen Fowler Flatt sold 1,500 shares of National HealthCare stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $237.08, for a total value of $355,620.00. Following the transaction, the chief executive officer owned 65,487 shares in the company, valued at approximately $15,525,657.96. This trade represents a 2.24% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 13.92% of the stock is owned by company insiders.

Analyst Ratings Changes

Several brokerages have recently issued reports on NHC. Royal Bank Of Canada upgraded National HealthCare to a “hold” rating in a research report on Monday, May 18th. BMO Capital Markets upgraded National HealthCare to a “hold” rating in a research report on Monday, May 18th. The Goldman Sachs Group upgraded National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. Finally, Robert W. Baird raised National HealthCare to a “strong-buy” rating in a research note on Monday, May 18th. Two investment analysts have rated the stock with a Strong Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, National HealthCare presently has a consensus rating of “Buy”.

Check Out Our Latest Report on National HealthCare

National HealthCare Price Performance

Shares of NHC opened at $233.40 on Monday. The firm has a 50-day moving average price of $216.53 and a 200 day moving average price of $187.69. The firm has a market capitalization of $3.66 billion, a PE ratio of 26.25 and a beta of 0.61. National HealthCare Corporation has a 52-week low of $110.58 and a 52-week high of $239.29.

National HealthCare (NYSEAMERICAN:NHCGet Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $1.74 EPS for the quarter. The company had revenue of $408.03 million for the quarter. National HealthCare had a net margin of 9.00% and a return on equity of 10.03%.

National HealthCare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Wednesday, September 30th. National HealthCare’s dividend payout ratio (DPR) is currently 61.89%.

National HealthCare Company Profile

(Free Report)

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.

Further Reading

Want to see what other hedge funds are holding NHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National HealthCare Corporation (NYSEAMERICAN:NHCFree Report).

Institutional Ownership by Quarter for National HealthCare (NYSEAMERICAN:NHC)

Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.